Relevance of thromboembolic events in hospitalized patients with acute and acute on chronic pancreatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036062

Enrollment

484

Registered

2025-02-10

Start date

2023-08-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K85

Interventions

Group 1: Patients with acute and acute on chronic pancreatitis, thromboembolic events

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: acute or acute on chronic pancreatitis

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Occurrence of any thromboembolic event during an episode of acute or acute on chronic pancreatitis.	—

Secondary

Measure	Time frame
1) any complication (composite endpoint: elevated liver enzymes, need for surgical/radiological/endoscopic intervention); 2) need for therapeutic anticoagulation; 3) pancreatitis severity; 4) resolution of thrombosis; 5) rehospitalization; 6) performance status; 7) etiology of pancreatitis; 8) hospitalization duration; 9) risk factors; 10) death.	—

Countries

Germany

Contacts

Public ContactJakob Vielhauer

Medizinische Klinik 2

jakob.vielhauer@med.uni-muenchen.de+4944000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026